GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » EV-to-EBIT

Novomics Co (XKRX:283100) EV-to-EBIT : -0.85 (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Novomics Co's Enterprise Value is ₩2,523.0 Mil. Novomics Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,963.8 Mil. Therefore, Novomics Co's EV-to-EBIT for today is -0.85.

The historical rank and industry rank for Novomics Co's EV-to-EBIT or its related term are showing as below:

XKRX:283100' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.71   Med: -4.19   Max: -0.61
Current: -0.85

During the past 7 years, the highest EV-to-EBIT of Novomics Co was -0.61. The lowest was -6.71. And the median was -4.19.

XKRX:283100's EV-to-EBIT is ranked worse than
100% of 425 companies
in the Biotechnology industry
Industry Median: 9.8 vs XKRX:283100: -0.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Novomics Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩18,050.3 Mil. Novomics Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,963.8 Mil. Novomics Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -16.42%.


Novomics Co EV-to-EBIT Historical Data

The historical data trend for Novomics Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co EV-to-EBIT Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - - -6.09

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT Get a 7-Day Free Trial - - - - -6.09

Competitive Comparison of Novomics Co's EV-to-EBIT

For the Biotechnology subindustry, Novomics Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Novomics Co's EV-to-EBIT falls into.



Novomics Co EV-to-EBIT Calculation

Novomics Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2523.045/-2963.81
=-0.85

Novomics Co's current Enterprise Value is ₩2,523.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novomics Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,963.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co  (XKRX:283100) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Novomics Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-2963.81/18050.271
=-16.42 %

Novomics Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩18,050.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novomics Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,963.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Novomics Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co (XKRX:283100) Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co (XKRX:283100) Headlines

No Headlines